No profile data available.
Summit Therapeutics Inc. (SMMT) is a healthcare company in the additional cancer treatment drugs industry, based in Miami, United States, with about 159 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$1.08 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $14.00 billion as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
Summit Therapeutics reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$14.00 billion as of December 4, 2025.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Bristol-Myers Squibb Company (BMY), Revolution Medicines, Inc. (RVMD), Exelixis, Inc. (EXEL), Halozyme Therapeutics, Inc. (HALO).